Medical technology as a key driver of rising health expenditure: Disentangling the relationship

ClinicoEconomics and Outcomes Research

Volumn 5, Issue 1, 2013, Pages 223-234

  Sorenson, Corinna ^a,b   Drummond, Michael ^b,c   Khan, Beena Bhuiyan ^a  

^a LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^b European Health Technology Institute for Socioeconomic Research (EHTI)   (Belgium)

^c UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Costs; Health expenditure; Health policy; Medical technology

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH SERVICE; HUMAN; MEDICAL INFORMATION; MEDICAL TECHNOLOGY; MULTIVARIATE ANALYSIS; SOCIOECONOMICS;

EID: 84878511206     PISSN: None     EISSN: 11786981     Source Type: Journal    
DOI: 10.2147/CEOR.S39634     Document Type: Article

References (55)

1. Organisation for Economic Co-operation and Development. OECD Health Data 2011. Paris, France: Organisation for Economic Co-operation and Development; 2011. Available from http://www.oecd.org/health/health-systems/healthataglance2011.htm.
2. Lubitz JD, Riley GF. Trends in Medicare payments in the last year of life. N Engl J Med. 1993;328:1092-1096.
3. Organisation for Economic Co-operation and Development. OECD Health at a Glance: Europe 2010. Paris, France: Organisation for Economic Co-operation and Development; 2010.
4. Organisation for Economic Co-operation and Development. Projecting OECD Health and Long Term Care Expenditures: What are the Main Drivers? Organisation for Economic Co-operation and Development Economic Department Working Paper, No 477; 2006. Available from: http://www.oecd.org/tax/public-finance/36085940.pdf. Accessed March 15, 2013.
5. Centers for Disease Control and Prevention. Health, United States, 2009 with Special Feature on Medical Technology. US Department of Health and Human Services: Hyattsville, MD; 2009. Available from: http://www.cdc.gov/nchs/data/hus/hus09.pdf. Accessed March 15, 2013.
6. Congressional Budget Office. Technological Change and The Growth of Health Care Spending. Congressional Budget Office: Washington, DC: Congressional Budget Office; 2008.
7. PricewaterhouseCoopers. The Factors Fueling Risking Healthcare Costs. Report prepared for the American Association of Health Plans; 2002. Available from: http://heartland.org/sites/all/modules/custom/heartland_migration/fles/pdfs/14621.pdf. Accessed March 15, 2013.
8. Fuchs VR. Economics, values, and health care reform. Am Econ Rev. 1996;86(1):1-24.
9. Cutler, D.M. Technology, Health Costs, and the NIH, Harvard University and the National Bureau of Economic Research. Paper prepared for the National Institutes of Health Economics Roundtable on Biomedical Research; September 1995.
10. Newhouse J. Medical care costs: How much welfare loss? J Econ Perspect. 1992;6:3-21.
11. Sorenson C, Drummond M. The socio-economic value of orthopaedic devices: Evidence and methodological challenges. Orthopedic Research and Reviews. 2012;4:87-96.
12. Centre for Review and Dissemination. Abstractors Guide for NHS EED. York, UK: Centre for Review and Dissemination; 2009. Available from: http://ospguides.ovid.com/OSPguides/cleeddb.htm.
13. Berndt ER, Cutler DM, Frank RG, Griliches Z, Newhouse J P, Triplett JE. Medical care prices and output. In: Culyer AJ, Newhouse J P, editors. Handbook of Health Economics, Volume 1A. Amsterdam, The Netherlands: Elsevier; 2000.
14. Okunade AA, Murthy VNR. Technology as a major driver of health care costs: a cointegration analysis of the Newhouse conjecture. J Health Econ. 2002;21:147-159.
15. Di Matteo L. The macro determinants of health expenditure in the United States and Canada: assessing the impact of income, age distribution and time. Health Policy. 2005;71:23-42.
16. Jones CI. Why have Health Expenditures as a Share of GDP Risen So Much? National Bureau of Economic Research Working Paper Series, No 9325; 2002. Available from: http://ideas.repec.org/p/nbr/nberwo/9325.html. Accessed March 15, 2013.
17. Peden EA, Freeland MS. A historical analysis of medical spending growth, 1960-1993. Health Affairs. 1995;14:235-247.
18. Dybczak K, Przywara B. The Role of Technology on Health Care Expenditure on the EU. European Economy - Economic Paper 400. Brussels, Belgium: Directorate General for Economic and Monetary Affairs, European Commission; 2010. Available from: http://ec.europa.eu/economy_fnance/publications/economic_paper/2010/ecp400_en.htm.
19. Smith SD, Heffer SK, Freeland MS. The Impact of Technological Change on Health Care Cost Increases: An Evaluation of the Literature. Health Care Financing Administration Working Paper; 2000. Available from: http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/downloads/tech_2000_0810.pdf.
20. Scitovski AA. Changes in the cost of treatment of selected illnesses, 1971-1981. Med Care. 1985;23:1345-1357.
21. Bryan S, Buxton M, Brenna E. Estimating the impact of a diffuse technology on the running costs of a hospital. Int J Technol Assess. 2000;16:787-798.
22. Weisbrod BA. The health care quadrilemma: an essay on technological change, insurance, quality of care and cost containment. J Econ Lit. 1991;29:523-532.
23. Rettig RA. Medical innovation duels cost containment. Health Aff (Millwood). 1994;13:7-27.
24. Fuchs VR. Health care for the elderly: how much? Who will pay for it? Health Aff (Millwood). 1999;18:11-21.
25. Cutler DM, McClellan M. Is technological change in medicine worth it? Health Aff (Millwood). 2001;20:11-29.
26. Baker LC. Managed care and technology adoption in health care: evidence from magnetic resonance imaging. J Health Econ. 2001;20:395-421.
27. Chernew M, Fendrick AM, Hirth RA. Managed care and medical technology: implications for cost growth. Health Aff (Millwood). 1997;16:196-206.
28. Cutler DM, Huckman RS. Technological development and medical productivity: the diffusion of angioplasty in New York state. J Health Econ. 2003;22:187-217.
29. Martin S, Rice N, Smith PC. Does health care spending improve health outcomes? Evidence from English programme budgeting data. J Health Econ. 2008;27:826-842.
30. Greenberg D, Rosenfeld K, Garcia LA, et al. In-hospital costs of self-expanding nitinol stent implantation vs. balloon angioplasty in the femoropopliteal artery (The VascuCoil Trial). J Vasc Interv Radiol. 2004;15:1065-1069.
31. Von Hout BA, Serruys P W, Lemos PA, et al. One-year cost-effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the Ravel trial. Heart. 2005;91:507-512.
32. Bagust A, Grayson AD, Palmer ND, Perry RA, Walley T. Cost-effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study. Heart. 2006;92:68-74.
33. Blank J, Vogelaar I. Specifying technical change: a research on the nature of technical change in Dutch hospital industry. Q Rev Econ Finance. 2004;44:448-463.
34. Bradley TB, Kominski G F. Contributions of case mix and intensity change to hospital cost increases. Health Care Financ Rev. 1992;14:151-163.
35. Mas N, Seinfeld J. Is managed care restraining the adoption of technology by hospitals? J Health Econ. 2008;27:1026-1045.
36. Cutler DM, McClellan M. The determinants of technological change in heart attack treatment. NBER Working Paper No 5751; 1996. Available from: http://ideas.repec.org/p/nbr/nberwo/5751.html. Accessed March 17, 2013.
37. Barros P, Martinez-Giralt X. Technological Adoption in Health Care. CEPR Discussion Papers 7558; 2009. Available from: http://ideas.repec.org/p/unl/unlfep/wp545.html. Accessed March 17, 2013.
38. Sorenson C, Kanavos P. Medical technology procurement in Europe: a cross-country comparison of current practice and policy. Health Policy. 2011;100:43-50.
39. Obremskey WT, Dail T, Jahangir AA. Value-based purchasing of medical devices. Clin Orthop Relat Res. 2012;470:1054-1064.
40. Cutler DM. The lifetime costs and benefits of medical technology. J Health Econ. 2007;26:1081-1100.
41. Lambooij MS, Westert G P. Diffusion of innovations in health care: does the structural context determine its direction? Int J Technol Assess. 2010;26:415-420.
42. March LM, Barcinilla AL, Cross MJ, et al. Costs and outcomes of total hip and knee joint replacement for rheumatoid arthritis. Clin Rheumatol. 2008;27:1235-1242.
43. Marinelli M, Soccetti A, Panfoli N, de Palma L. Cost-effectiveness of cemented versus cementless total hip anthroplasty. A Markov decision analysis based on implant cost. J Orthop Traumatol. 2008;9:23-28.
44. Banz K. Cardiac resynchronization therapy (CRT) in heart failure: a model to assess the economic value of this new medical technology. Value Health. 2005;8:128-139.
45. Brunner-La Rocca H P, Kaiser C, Bernheim A, et al. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEff Ektivitäts Trial (BASKET): an 18-month analysis. Lancet. 2007;370:155-159.
46. Hay J W. Hospital cost drivers: an evaluation of 1998-2001 state-level data. Am J Manag Care. 2003;9:SP13-SP24.
47. Donavan GD, King G. Estimates of Medical Device Spending in the United States. Advanced Medical Technology Association; 2011. Available from: www.amsa.org/king_paper_medical_device_spending.sfb.ashx
48. Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess. 1990;6:57-75.
49. Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960-2000. N Engl J Med. 2006;355:920-927.
50. Skinner J, Staiger D. Technology Diffusion and Productivity Growth in Health Care. National Bureau of Economic Research Working Paper Series, No 14865; 2009. Available from: http://www.dartmouth.edu/jskinner/documents/SkinnerStaigerw14865_000.pdf. Accessed March 17, 2013.
51. Bozic KJ, Morshed S, Silverstein MD, Rubash HE, Kahn JG. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics: the case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am. 2006;88:706-714.
52. Singh S, Sun H, Anis AH. Cost-effectiveness of hip protectors in the prevention of osteoporosis related hip fractures in elderly nursing home residents. J Rheumatol. 2004;31:1607-1613.
53. Segui-Gomez M, Keuffel E, Frick KD. Cost and effectiveness of hip protectors among the elderly. Int J Technol Assess. 2002;18:55-66.
54. Fuchs VR, Sox HC. Physicians' views of the relative importance of thirty medical innovations. Health Aff (Millwood). 2001;20:30-42.
55. Sorenson C, Tarricone R, Siebert M, Drummond M. Applying health economics for policy decision making: how much do devices differ from drugs? Europace. 2011;13 SUPPL 2:ii54-ii58.